Luminex Corporation develops, manufactures, and sells proprietary biological testing technologies and products for the diagnostics, pharmaceutical, and life sciences industries worldwide. The Company's products include Luminex LX 100/200 that integrates fluidics, optics, and digital signal processing, FLEXMAP 3D system for use as a general laboratory instrument, and other diagnostics systems and platforms. It also offers laboratory software suites and data management software solutions. In addition, the Company provides reagents, assays and test cartridges for various purposes. Further, it offers specialty product family and instrumentation products, as well as operates as an original equipment manufacturer of custom reagents and instrumentation.

Company Growth (employees)
Type
Public
HQ
Austin, US
Founded
1995
Size (employees)
914 (est)
Luminex was founded in 1995 and is headquartered in Austin, US

Luminex Office Locations

Luminex has offices in Austin, Madison, 's-Hertogenbosch, Toronto and in 4 other locations
Austin, US (HQ)
12212 Technology Blvd, Suite 130
Madison, US
1224 Deming Way
Toronto, CA
439 University Ave Suite 900
Shanghai, CN
14/F C&D, Building 7, Pujiang Hi-Tech Park 2388 Chenhang Road, Minhang District
Tokyo, JP
Kamiyacho Azabudai Bldg 8F 1-7-2 Azabudai Minato-ku
's-Hertogenbosch, NL
1 Het Zuiderkruis
Show all (8)

Luminex Financials and Metrics

Luminex Financials

Luminex's revenue was reported to be $270.6 m in FY, 2016
USD

Revenue (Q2, 2017)

76.5 m

Gross profit (Q2, 2017)

50.1 m

Gross profit margin (Q2, 2017), %

65%

Net income (Q2, 2017)

5.5 m

EBIT (Q2, 2017)

7.5 m

Market capitalization (16-Feb-2018)

853.2 m

Cash (30-Jun-2017)

103.7 m
Luminex's current market capitalization is $853.2 m.
USDFY, 2010FY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Revenue

10.7 m227 m237.7 m270.6 m

Revenue growth, %

2021%5%14%

Cost of goods sold

69.8 m67.1 m69 m91 m

Gross profit

(59.1 m)159.9 m168.7 m179.7 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Revenue

50.8 m56.6 m55.6 m56.7 m57.7 m58.9 b60.6 b63 m64.2 m71.2 m77.8 m76.5 m

Cost of goods sold

20 m16.6 m17.5 m17.7 m17.5 m15.6 b18.8 b18.2 m19.2 m25.6 m25 m26.4 m

Gross profit

30.8 m40 m38.1 m39 m40.2 m43.3 b41.8 b44.8 m44.9 m45.7 m52.8 m50.1 m

Gross profit Margin, %

61%71%69%69%70%73%69%71%70%64%68%65%
USDY, 2009Y, 2010Y, 2011Y, 2012Y, 2013Y, 2014Y, 2015FY, 2016

Cash

90.8 m89.5 m58.3 m42.8 m67.9 m91.7 m128.5 m93.5 m

Accounts Receivable

30.9 m29.1 m28.9 m32.4 m

Inventories

40.8 m

Current Assets

146.4 m177 m209.5 m173.7 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017

Cash

57.2 m77.4 m86.7 m89.1 m94.9 m111.1 m119.6 m134.3 m81.7 m84.1 m86.5 m103.7 m

Accounts Receivable

30.2 m27 m27.6 m27.4 m25.1 m22.2 m26.2 m29.4 m27 m30 m37 m33.1 m

Inventories

29.7 m30.9 m31.2 m33.1 m33.7 m32.6 m29.3 m31.2 m41.5 m41.5 m43.7 m47.1 m

Current Assets

130 m150.3 m157.5 m163.1 m172.2 m192.7 m201.9 m217.7 m159.2 m164.9 m173.5 m192.1 m
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

7.1 m39 m36.9 m13.8 m

Depreciation and Amortization

15.9 m14.2 m

Accounts Receivable

2.3 m2 m

Accounts Payable

962 k841 k
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

796 k6 m4.7 m5.6 m7.5 m2.6 b6.4 b8.8 m5.7 m2.8 m9.2 m

Accounts Receivable

27.6 m27.4 m25.1 m22.2 m26.2 m29.4 m27 m30 m37 m

Accounts Payable

8.9 m10.1 m11 m8 m9.3 m6.9 m11.3 m9.9 m9.1 m

Income Taxes Paid

(1.6 m)(2.2 m)(45 k)(2.9 m)
Y, 2017

Financial Leverage

1.1 x
Show all financial metrics

Luminex Operating Metrics

FY, 2015FY, 2016

Patents Pending

199166

Patents Issued

364563
Show all operating metrics

Luminex Market Value History

Luminex Median Salaries

Source: 16 public H-1B filings from Luminex

Luminex's Web-traffic and Trends

Luminex Online and Social Media Presence

Luminex News and Updates

Global SNP Genotyping Highlights Market Size, Opportunities, Trends and Forecast 2022

The report provides in depth study of “SNP Genotyping” using SWOT analysis i.e. Strength, Weakness, Opportunities and Threat to the organization Posted via Industry Today. Follow us on Twitter @IndustryToday

Luminex Company Life and Culture

You may also be interested in